Document Detail

Biomarkers in community-acquired pneumonia: A state-of-the-art review.
MedLine Citation:
PMID:  23184211     Owner:  NLM     Status:  In-Data-Review    
Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications and for CAP diagnosis, prognosis and follow-up treatment. This non-systematic state-of-the-art review presents the biological and clinical features of biomarkers in CAP patients, including procalcitonin, C-reactive protein, copeptin, pro-ANP (atrial natriuretic peptide), adrenomedullin, cortisol and D-dimers.
Renato Seligman; Luis Francisco Ramos-Lima; Vivian do Amaral Oliveira; Carina Sanvicente; Elyara F Pacheco; Karoline Dalla Rosa
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinics (São Paulo, Brazil)     Volume:  67     ISSN:  1980-5322     ISO Abbreviation:  Clinics (Sao Paulo)     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101244734     Medline TA:  Clinics (Sao Paulo)     Country:  Brazil    
Other Details:
Languages:  eng     Pagination:  1321-5     Citation Subset:  IM    
Departamento de Medicina Interna, Hospital de ClÃ-nicas de Porto Alegre (HCPA), Faculdade de Medicina, Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Quality of life measurements in patients with osteoporosis and fractures.
Next Document:  Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy.